Paid Clinical Trials for Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements

  1. Home
  2. Jobs
  3. Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements
Showing the single result

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

by CTG
in Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements, Recurrent High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements, Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified
Other
California
Deadline:
08/01/2030